The pharmacoepigenetic paradigm in cancer treatment
Epigenetic modifications, characterized by changes in gene expression without altering the DNA sequence, play a crucial role in the development and progression of cancer by significantly influencing gene activity and cellular function. This insight has led to the development of a novel class of ther...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 April 2024
|
| In: |
Frontiers in pharmacology
Year: 2024, Jahrgang: 15, Pages: 1-14 |
| ISSN: | 1663-9812 |
| DOI: | 10.3389/fphar.2024.1381168 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fphar.2024.1381168 Resolving-System, kostenfrei, Volltext: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1381168/full 
|
| Verfasserangaben: | Belén Ocaña-Paredes, Sebastián Rivera-Orellana, David Ramírez-Sánchez, Juliana Montalvo-Guerrero, María Paula Freire, Samantha Espinoza-Ferrao, Adriana Altamirano-Colina, Paulina Echeverría-Espinoza, María José Ramos-Medina, Gabriela Echeverría-Garcés, Danilo Granda-Moncayo, Andrea Jácome-Alvarado, María Gabriela Andrade and Andrés López-Cortés |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1920190759 | ||
| 003 | DE-627 | ||
| 005 | 20250717002030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250320s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2024.1381168 |2 doi | |
| 035 | |a (DE-627)1920190759 | ||
| 035 | |a (DE-599)KXP1920190759 | ||
| 035 | |a (OCoLC)1528043402 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ocaña-Paredes, Belén |e VerfasserIn |0 (DE-588)1360697594 |0 (DE-627)1920192964 |4 aut | |
| 245 | 1 | 4 | |a The pharmacoepigenetic paradigm in cancer treatment |c Belén Ocaña-Paredes, Sebastián Rivera-Orellana, David Ramírez-Sánchez, Juliana Montalvo-Guerrero, María Paula Freire, Samantha Espinoza-Ferrao, Adriana Altamirano-Colina, Paulina Echeverría-Espinoza, María José Ramos-Medina, Gabriela Echeverría-Garcés, Danilo Granda-Moncayo, Andrea Jácome-Alvarado, María Gabriela Andrade and Andrés López-Cortés |
| 264 | 1 | |c 24 April 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 20.03.2025 | ||
| 520 | |a Epigenetic modifications, characterized by changes in gene expression without altering the DNA sequence, play a crucial role in the development and progression of cancer by significantly influencing gene activity and cellular function. This insight has led to the development of a novel class of therapeutic agents, known as epigenetic drugs. These drugs, including histone deacetylase inhibitors, histone acetyltransferase inhibitors, histone methyltransferase inhibitors, and DNA methyltransferase inhibitors, aim to modulate gene expression to curb cancer growth by uniquely altering the epigenetic landscape of cancer cells. Ongoing research and clinical trials are rigorously evaluating the efficacy of these drugs, particularly their ability to improve therapeutic outcomes when used in combination with other treatments. Such combination therapies may more effectively target cancer and potentially overcome the challenge of drug resistance, a significant hurdle in cancer therapy. Additionally, the importance of nutrition, inflammation control, and circadian rhythm regulation in modulating drug responses has been increasingly recognized, highlighting their role as critical modifiers of the epigenetic landscape and thereby influencing the effectiveness of pharmacological interventions and patient outcomes. Epigenetic drugs represent a paradigm shift in cancer treatment, offering targeted therapies that promise a more precise approach to treating a wide spectrum of tumors, potentially with fewer side effects compared to traditional chemotherapy. This progress marks a step towards more personalized and precise interventions, leveraging the unique epigenetic profiles of individual tumors to optimize treatment strategies. | ||
| 650 | 4 | |a clinical trials | |
| 650 | 4 | |a DNA methyltransferase inhibitors | |
| 650 | 4 | |a epigenetic drugs | |
| 650 | 4 | |a histone acetyltransferase inhibitors | |
| 650 | 4 | |a histone deacetylase inhibitors | |
| 650 | 4 | |a histone methyltransferase inhibitors | |
| 700 | 1 | |a Rivera-Orellana, Sebastián |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ramírez-Sánchez, David |e VerfasserIn |4 aut | |
| 700 | 1 | |a Montalvo-Guerrero, Juliana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Freire, María Paula |e VerfasserIn |4 aut | |
| 700 | 1 | |a Espinoza-Ferrao, Samantha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Altamirano-Colina, Adriana |e VerfasserIn |4 aut | |
| 700 | 1 | |a Echeverría-Espinoza, Paulina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ramos Medina, María José |e VerfasserIn |0 (DE-588)136069725X |0 (DE-627)1920191755 |4 aut | |
| 700 | 1 | |a Echeverría-Garcés, Gabriela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Granda-Moncayo, Danilo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jácome-Alvarado, Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Andrade, María Gabriela |e VerfasserIn |4 aut | |
| 700 | 1 | |a López-Cortés, Andrés |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d Lausanne : Frontiers Media, 2010 |g 15(2024) vom: Apr., Artikel-ID 1381168, Seite 1-14 |h Online-Ressource |w (DE-627)642889392 |w (DE-600)2587355-6 |w (DE-576)335527108 |x 1663-9812 |7 nnas |a The pharmacoepigenetic paradigm in cancer treatment |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g month:04 |g elocationid:1381168 |g pages:1-14 |g extent:14 |a The pharmacoepigenetic paradigm in cancer treatment |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fphar.2024.1381168 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1381168/full |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250320 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 136069725X |a Ramos Medina, María José |m 136069725X:Ramos Medina, María José |p 9 | ||
| 999 | |a KXP-PPN1920190759 |e 4688767285 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Belén Ocaña-Paredes, Sebastián Rivera-Orellana, David Ramírez-Sánchez, Juliana Montalvo-Guerrero, María Paula Freire, Samantha Espinoza-Ferrao, Adriana Altamirano-Colina, Paulina Echeverría-Espinoza, María José Ramos-Medina, Gabriela Echeverría-Garcés, Danilo Granda-Moncayo, Andrea Jácome-Alvarado, María Gabriela Andrade and Andrés López-Cortés"]},"id":{"doi":["10.3389/fphar.2024.1381168"],"eki":["1920190759"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"24 April 2024"}],"relHost":[{"origin":[{"publisherPlace":"Lausanne","dateIssuedDisp":"2010-","publisher":"Frontiers Media","dateIssuedKey":"2010"}],"id":{"issn":["1663-9812"],"zdb":["2587355-6"],"eki":["642889392"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Frontiers in pharmacology","title_sort":"Frontiers in pharmacology"}],"pubHistory":["2010 -"],"part":{"year":"2024","pages":"1-14","volume":"15","text":"15(2024) vom: Apr., Artikel-ID 1381168, Seite 1-14","extent":"14"},"note":["Gesehen am 08.09.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"The pharmacoepigenetic paradigm in cancer treatmentFrontiers in pharmacology","language":["eng"],"recId":"642889392"}],"physDesc":[{"noteIll":"Illustrationen","extent":"14 S."}],"person":[{"family":"Ocaña-Paredes","given":"Belén","display":"Ocaña-Paredes, Belén","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Rivera-Orellana, Sebastián","roleDisplay":"VerfasserIn","role":"aut","family":"Rivera-Orellana","given":"Sebastián"},{"given":"David","family":"Ramírez-Sánchez","role":"aut","display":"Ramírez-Sánchez, David","roleDisplay":"VerfasserIn"},{"family":"Montalvo-Guerrero","given":"Juliana","roleDisplay":"VerfasserIn","display":"Montalvo-Guerrero, Juliana","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Freire, María Paula","given":"María Paula","family":"Freire"},{"family":"Espinoza-Ferrao","given":"Samantha","roleDisplay":"VerfasserIn","display":"Espinoza-Ferrao, Samantha","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Altamirano-Colina, Adriana","role":"aut","family":"Altamirano-Colina","given":"Adriana"},{"given":"Paulina","family":"Echeverría-Espinoza","role":"aut","display":"Echeverría-Espinoza, Paulina","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Ramos Medina, María José","role":"aut","family":"Ramos Medina","given":"María José"},{"role":"aut","display":"Echeverría-Garcés, Gabriela","roleDisplay":"VerfasserIn","given":"Gabriela","family":"Echeverría-Garcés"},{"family":"Granda-Moncayo","given":"Danilo","display":"Granda-Moncayo, Danilo","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Jácome-Alvarado, Andrea","roleDisplay":"VerfasserIn","role":"aut","family":"Jácome-Alvarado","given":"Andrea"},{"given":"María Gabriela","family":"Andrade","role":"aut","display":"Andrade, María Gabriela","roleDisplay":"VerfasserIn"},{"display":"López-Cortés, Andrés","roleDisplay":"VerfasserIn","role":"aut","family":"López-Cortés","given":"Andrés"}],"title":[{"title_sort":"pharmacoepigenetic paradigm in cancer treatment","title":"The pharmacoepigenetic paradigm in cancer treatment"}],"recId":"1920190759","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 20.03.2025"]} | ||
| SRT | |a OCANAPAREDPHARMACOEP2420 | ||